The shares of Dr Reddy's Laboratories saw a positive momentum from March till September, but from September 21, the stock has been under pressure and it has underperformed not only Nifty but also the Nifty pharma Index.

However, on Monday, Dr Reddy's Laboratories’ stock ended higher with a gain of around 3.50 percent. The move was backed by both stronger volumes as well as good delivery.

CNBC-TV18’s Nigel D'Souza brings you the details.

Watch this video for more.

(Edited by : Ankit Gohel)